Last reviewed · How we verify
NCT04644640
Telerehabilitation Following Meniscectomy
NA trial testing Telerehabilitation Therapy in Meniscectomy in 60 participants. Completed in 1 April 2023.
30 August 2021
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 11 November 2020 |
| Primary completion | 30 August 2021 |
| Estimated completion | 1 April 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Telerehabilitation Therapy
- In-person Rehabilitation Therapy
Conditions studied
- Meniscectomy — all drugs for Meniscectomy →
Sponsor
NYU Langone Health — full company profile →
Who can join
Adults 18 to 75, any sex, with Meniscectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Telerehabilitation is a form of tele-treatment in which rehabilitation services are dispensed at patients' home utilizing video telecommunication services with real-time synchronous exchange of information. Since telerehabilitation was found to be equally effective as conventional therapy, it was being practiced even before the COVID times, however it was truly valuable during the lockdown. The advantages of telerehabilitation include reducing unnecessary travel to the hospital and person to person contact while maintaining social distancing. While some of the patients are truly staying at remote areas, others are unable to manage travel in the lockdown period. Telemedicine offers the opportunity to deliver rehabilitative services in the patients' home, closing geographic, physical, and motivational gaps. Punctuality on either side is also assured since the travel times are saved on both the ends. The purpose of the proposed study is to evaluate telerehabilitation vs in-person rehabilitation following Meniscectomy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Despite Equivalent Clinical Outcomes, Patients Report Less Satisfaction With Telerehabilitation Versus Standard In-Office Rehabilitation After Arthroscopic Meniscectomy: A Randomized Controlled Trial.
Mojica ES, Vasavada K, Hurley ET, Lin CC, et al · · 2023 · cited 4× · PMID 37101883 · DOI 10.1016/j.asmr.2023.01.006
Verify or expand the search:
- PubMed search for NCT04644640
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Telerehabilitation Therapy
Trials testing the same drug.
- NCT04541940 — TeleRehabilitation Following ACL Reconstruction · NA · completed
- NCT04541953 — TeleRehabilitation Following Arthroscopic Rotator Cuff Repair · NA · completed
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04644640 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 3 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04644640.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing